Management of Anemia in Patients Receiving Protease Inhibitors

Por Harrison, Stephen A.
Publicado em 2012

Utilization of FibroScan Testing in Hepatitis C Virus Management

Por Harrison, Stephen A.
Publicado no Gastroenterol Hepatol (N Y) (2015)

Management of Lysosomal Acid Lipase Deficiency for the Gastroenterologist and Hepatologist

Por Harrison, Stephen A.
Publicado no Gastroenterol Hepatol (N Y) (2016)

Hepatitis C Virus Infection and Nonalcoholic Steatohepatitis

Por Patel, Anish, Harrison, Stephen A.
Publicado em 2012

Benefits of lifestyle modification in NAFLD

Por Harrison, Stephen A, Day, Christopher Paul
Publicado em 2007

Current Status of Therapy in Nonalcoholic Fatty Liver Disease

Por McNear, Scott, Harrison, Stephen A.
Publicado em 2009

Hepatitis C Virus and Insulin Resistance/Diabetes Mellitus

Por Torres, Dawn M., Harrison, Stephen A.
Publicado em 2008

Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment

Por Stengel, Joel Z., Harrison, Stephen A.
Publicado no Gastroenterol Hepatol (N Y) (2006)

Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease

Por Jayakumar, Saumya, Harrison, Stephen A., Loomba, Rohit
Publicado no Curr Hepatol Rep (2016)

The Role of Consensus Interferon in the Current Treatment of Chronic Hepatitis C Viral Infection

Por Fish, Eleanor N., Harrison, Stephen A., Hassanein, Tarek
Publicado em 2008

Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials

Por Hannah, William N., Torres, Dawn M., Harrison, Stephen A.
Publicado no Gastroenterol Hepatol (N Y) (2016)

Is Moderate Alcohol Use in Non-Alcoholic Fatty Liver Disease Good or Bad? A Critical Review

Por Ajmera, Veeral H., Terrault, Norah A., Harrison, Stephen A.
Publicado no Hepatology (2017)

Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease

Por Touzin, Nadege T., Bush, Kelvin N.V., Williams, Christopher D., Harrison, Stephen A.
Publicado em 2011

Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways

Por Perumpail, Ryan B, Liu, Andy, Wong, Robert J, Ahmed, Aijaz, Harrison, Stephen A
Publicado no World J Hepatol (2015)

Controversies in the Diagnosis and Management of NAFLD and NASH

Por Rinella, Mary E., Loomba, Rohit, Caldwell, Stephen H., Kowdley, Kris, Charlton, Michael, Tetri, Brent, Harrison, Stephen A.
Publicado em 2014

Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial

Por Eckard, Carly, Cole, Renee, Lockwood, Joshua, Torres, Dawn M., Williams, Christopher D., Shaw, Janet C., Harrison, Stephen A.
Publicado em 2013

A Pragmatic Approach to Professional and Ethical Dilemmas

Por Meyer, Eric G., Ford, Caelan M. J., Thaxton, Robert E., Anders, Gregg T., Jefferson, Thomas C., Fruendt, Jonathan C., Harrison, Stephen A.
Publicado em 2014

Practice patterns in NAFLD and NASH: real life differs from published guidelines

Por Rinella, Mary E., Lominadze, Zurabi, Loomba, Rohit, Charlton, Michael, Neuschwander-Tetri, Brent A., Caldwell, Stephen H., Kowdley, Kris, Harrison, Stephen A.
Publicado no Therap Adv Gastroenterol (2016)

Mixed Lineage Kinase 3 Mediates Release of C-X-C Motif Ligand 10-Bearing Chemotactic Extracellular Vesicles from Lipotoxic Hepatocytes

Por Ibrahim, Samar H., Hirsova, Petra, Tomita, Kyoko, Bronk, Steven F., Werneburg, Nathan W., Harrison, Stephen A., Goodfellow, Val S., Malhi, Harmeet, Gores, Gregory J.
Publicado no Hepatology (2015)

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States

Por Siddique, Osama, Joseph-Talreja, Mairin, Yoo, Eric R., Perumpail, Ryan B., Cholankeril, George, Harrison, Stephen A., Younossi, Zobair M., Wong, Robert J., Ahmed, Aijaz
Publicado no J Clin Transl Hepatol (2017)